FDA Approved: YORVIPATH — Supplemental Application (Ascendis Pharma, Endocrinology, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for YORVIPATH (palopegteriparatide) from Ascendis Pharma Endocrinology, Inc. The approval indicates a regulatory cha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• YORVIPATH (palopegteriparatide)

Snippet

SUPPL AP for YORVIPATH (PALOPEGTERIPARATIDE)